Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Raw Materials (2016 - 2025)

Historic Raw Materials for Alkermes (ALKS) over the last 15 years, with Q3 2025 value amounting to $66.2 million.

  • Alkermes' Raw Materials fell 1546.57% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.2 million, marking a year-over-year decrease of 1546.57%. This contributed to the annual value of $72.1 million for FY2024, which is 101.24% up from last year.
  • According to the latest figures from Q3 2025, Alkermes' Raw Materials is $66.2 million, which was down 1546.57% from $68.4 million recorded in Q2 2025.
  • Alkermes' 5-year Raw Materials high stood at $78.3 million for Q3 2024, and its period low was $46.3 million during Q3 2021.
  • Moreover, its 5-year median value for Raw Materials was $61.1 million (2022), whereas its average is $62.5 million.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 3431.9% in 2021, then plummeted by 1546.57% in 2025.
  • Over the past 5 years, Alkermes' Raw Materials (Quarter) stood at $56.1 million in 2021, then grew by 8.8% to $61.1 million in 2022, then rose by 16.95% to $71.4 million in 2023, then increased by 1.01% to $72.1 million in 2024, then dropped by 8.2% to $66.2 million in 2025.
  • Its Raw Materials stands at $66.2 million for Q3 2025, versus $68.4 million for Q2 2025 and $69.7 million for Q1 2025.